AMPH - Amphastar Pharmaceuticals Inc
IEX Last Trade
48.75
-0.110 -0.226%
Share volume: 205,062
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$48.86
-0.11
-0.23%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-10 | 2022-08-09 | 2022-11-08 | 2023-03-01 | 2023-05-09 | 2023-08-09 | 2023-11-08 | 2024-02-29 | |
| Assets | |||||||||
| Total Assets | 716.238 M | 723.719 M | 726.695 M | 741.987 M | 773.656 M | 1.378 B | 1.545 B | 1.513 B | |
| Current Assets | 364.415 M | 377.145 M | 384.222 M | 378.319 M | 407.670 M | 384.554 M | 543.005 M | 489.600 M | |
| Inventories | 95.147 M | 98.733 M | 103.250 M | 103.584 M | 103.647 M | 104.617 M | 109.978 M | 105.833 M | |
| Other Current Assets | 6.657 M | 11.776 M | 17.351 M | 7.734 M | 8.058 M | 7.201 M | 7.702 M | 9.583 M | |
| Short Term Investments | 6.657 M | 11.776 M | 17.351 M | 7.734 M | 8.058 M | 7.201 M | 7.702 M | 9.583 M | |
| Total Receivables | 73.166 M | 80.810 M | 77.099 M | 88.804 M | 100.638 M | 104.715 M | 118.990 M | 114.943 M | |
| Current Cash | 187.010 M | 183.391 M | 184.087 M | 175.762 M | 192.892 M | 163.136 M | 299.876 M | 256.806 M | |
| Total Non-current Assets | 351.823 M | 346.574 M | 342.473 M | 363.668 M | 365.986 M | 993.712 M | 1.002 B | 1.023 B | |
| Property Plant Equipment | 243.248 M | 237.564 M | 232.741 M | 238.266 M | 243.479 M | 278.526 M | 280.836 M | 282.746 M | |
| Other Assets | 16.579 M | 18.884 M | 21.150 M | 21.609 M | 19.242 M | 20.926 M | 25.909 M | 26.474 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 38.436 M | 37.700 M | 37.037 M | 37.298 M | 37.179 M | 625.603 M | 619.351 M | 613.295 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 716.238 M | 723.719 M | 726.695 M | 741.987 M | 773.656 M | 1.378 B | 1.545 B | 1.513 B | |
| Total liabilities | 236.713 M | 224.412 M | 221.530 M | 213.329 M | 225.079 M | 789.031 M | 949.493 M | 873.491 M | |
| Total current liabilities | 114.364 M | 103.634 M | 102.190 M | 94.862 M | 105.635 M | 251.285 M | 257.963 M | 225.407 M | |
| Accounts Payable | 23.843 M | 31.071 M | 19.963 M | 20.501 M | 21.979 M | 18.832 M | 31.970 M | 25.438 M | |
| Other liabilities | 22.025 M | 21.863 M | 20.721 M | 21.790 M | 22.400 M | 24.858 M | 22.924 M | 28.784 M | |
| Current long term debt | 2.159 M | 2.057 M | 1.680 M | 3.046 M | 2.168 M | 12.920 M | 433.000 K | 436.000 K | |
| Long term debt | 74.348 M | 73.871 M | 74.011 M | 72.839 M | 72.872 M | 488.280 M | 638.206 M | 589.579 M | |
| Other liabilities | 22.025 M | 21.863 M | 20.721 M | 21.790 M | 22.400 M | 24.858 M | 22.924 M | 28.784 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 479.525 M | 499.307 M | 505.165 M | 528.658 M | 548.577 M | 589.235 M | 595.140 M | 639.421 M | |
| Common stock | 48.138 M | 48.864 M | 48.904 M | 48.298 M | 48.000 M | 48.404 M | 48.701 M | 47.955 M | |
| Retained earnings | 204.590 M | 221.936 M | 237.810 M | 271.723 M | 297.755 M | 323.880 M | 373.102 M | 409.268 M |